Please use this identifier to cite or link to this item:
http://20.193.157.4:9595/xmlui/handle/123456789/1332Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Devarmani SS, VG Warad, Mohammed Ayaz. | - |
| dc.date.accessioned | 2019-11-23T12:48:50Z | - |
| dc.date.available | 2019-11-23T12:48:50Z | - |
| dc.date.issued | 2015 | - |
| dc.identifier.uri | http://hdl.handle.net/123456789/1332 | - |
| dc.description.abstract | Cardiovascular morbidity & mortality are predominantly seen in diabetic patients with dyslipidemia. But unfortunately, most of the diabetic patients are unaware of their dyslipidemic status. By diagnosing & initiating steps to normalize the levels of circulating lipids, the odds of developing cardiovascular complications and mortality can be decreased. Long term glycemic control can be monitored using glycosylated hemoglobin (HbA1c | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | BLDE(Deemed to be University) | en_US |
| dc.subject | HbA1c marker, Diabetic dyslipidemia, Type 2 diabetes mellitus | en_US |
| dc.title | HbA1c as a Marker of Diabetic Dyslipidemia in Type 2 Diabetic Patients: A Cross Sectional Study. | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | Faculty of General Medicine | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.